Page 67 - Fresenius Kabi Acute Care 2017 Product Catalog

Flexibility. By design.
Glucagon for Injection for diagnostic use — a recent addition to the Fresenius Kabi Specialty Injectable Portfolio — offering pharmacies the flexibility that comes with choice.
Our people and processes are focused on one goal: helping our customers secure essential products for their patients. And because everything we do can impact a patient’s life, we strive to get the details right.
Everything happens by design.
1.888.386.1300 | www.fresenius-kabi.us
Please see full prescribing information at www.fresenius-kabi.us.
© 2017, Fresenius Kabi USA, LLC. All Rights Reserved.
INDICATIONS AND USAGE Glucagon for Injection is a gastrointestinal motility inhibitor indicated for use as a diagnostic aid during radiologic examinations to temporarily inhibit movement of the gastrointestinal (GI) tract
Limitations of Use: Fresenius Kabi Glucagon for Injection is not indicated for the emergency treatment of hypoglycemia
CONTRAINDICATIONS • Pheochromocytoma • Insulinoma • Glucagonoma
WARNINGS AND PRECAUTIONS • Hyperglycemia in patients with diabetes: Monitor blood glucose and treat with insulin if indicated • Increased blood pressure and heart rate in patients with cardiac disease: Monitor patients with known cardiac disease • Allergic reactions including anaphylactic shock with breathing difficulties, and hypotension, generalized rash: Discontinue and treat as indicated
ADVERSE REACTIONS Adverse reactions seen with glucagon are transient changes in blood pressure, increase in heart rate, hypersensitivity reactions, nausea and vomiting, and hypoglycemia
To report SUSPECTED ADVERSE REACTIONS, contact Fresenius Kabi USA, LLC at 1-800-551-7176 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.